Mechanisms of bone pain: Progress in research from bench to bedside

G Zhen, Y Fu, C Zhang, NC Ford, X Wu, Q Wu, D Yan… - Bone Research, 2022 - nature.com
The field of research on pain originating from various bone diseases is expanding rapidly,
with new mechanisms and targets asserting both peripheral and central sites of action. The …

The interplay between chronic pain, opioids, and the immune system

V Malafoglia, S Ilari, L Vitiello, M Tenti… - The …, 2022 - journals.sagepub.com
Chronic pain represents one of the most serious worldwide medical problems, in terms of
both social and economic costs, often causing severe and intractable physical and …

Apollo‐2: a randomized, placebo and active‐controlled phase III study investigating oliceridine (TRV 130), a G protein–biased ligand at the μ‐opioid receptor, for …

NK Singla, F Skobieranda, DG Soergel… - Pain …, 2019 - Wiley Online Library
Objectives The clinical utility of conventional IV opioids is limited by the occurrence of opioid‐
related adverse events. Oliceridine is a novel G protein–biased μ‐opioid receptor agonist …

Biased signaling by endogenous opioid peptides

I Gomes, S Sierra, L Lueptow, A Gupta… - Proceedings of the …, 2020 - National Acad Sciences
Opioids, such as morphine and fentanyl, are widely used for the treatment of severe pain;
however, prolonged treatment with these drugs leads to the development of tolerance and …

Fentanyl and the fluorinated fentanyl derivative NFEPP elicit distinct hydrogen-bond dynamics of the opioid receptor

S Lešnik, U Bren, T Domratcheva… - Journal of chemical …, 2023 - ACS Publications
The development of safe therapeutics to manage pain is of central interest for biomedical
applications. The fluorinated fentanyl derivative N-(3-fluoro-1-phenethylpiperidin-4-yl)-N …

The downregulation of opioid receptors and neuropathic pain

L Li, J Chen, YQ Li - International Journal of Molecular Sciences, 2023 - mdpi.com
Neuropathic pain (NP) refers to pain caused by primary or secondary damage or dysfunction
of the peripheral or central nervous system, which seriously affects the physical and mental …

Structural insights accelerate the discovery of opioid alternatives

T Che, BL Roth - Annual review of biochemistry, 2021 - annualreviews.org
Opioids such as morphine and oxycodone are analgesics frequently prescribed for the
treatment of moderate or severe pain. Unfortunately, these medications are associated with …

ATHENA: a phase 3, open-label study of the safety and effectiveness of oliceridine (TRV130), a G-protein selective agonist at the µ-opioid receptor, in patients with …

SD Bergese, M Brzezinski, GB Hammer… - Journal of Pain …, 2019 - Taylor & Francis
Background Pain management with conventional opioids can be challenging due to dose-
limiting adverse events (AEs), some of which may be related to the simultaneous activation …

Advances in the characterization of negative affect caused by acute and protracted opioid withdrawal using animal models

D Ozdemir, F Allain, BL Kieffer, E Darcq - Neuropharmacology, 2023 - Elsevier
Opioid use disorder (OUD) is a chronic brain disease which originates from long-term
neuroadaptations that develop after repeated opioid consumption and withdrawal episodes …

Peripheral nitric oxide signaling directly blocks inflammatory pain

FIF Gomes, FQ Cunha, TM Cunha - Biochemical pharmacology, 2020 - Elsevier
Pain is a classical sign of inflammation, and sensitization of primary sensory neurons (PSN)
is the most important mediating mechanism. This mechanism involves direct action of …